tirzepatide egfr cut-off uEGF/Cr and kidney outcomes in CKD. Higher baseline levels predicted lower risk. One-year increases pointed to better outcomes independent of and albuminuria. SGLT2 inhibitors slowed decline, with consistent findings across diverse Tirzepatide reduces albuminuria among adults

Oral options may expand access and offer more flexibility, which could play an important role in long-term treatment adherence and individualized care, said Yu-Lun Liu, co-author of the study and Associate Professor of Biostatistics at UT Southwestern Medical Center

This timing optimises absorption, which occurs primarily in the small intestine

All clinical decisions regarding patient eligibility, dosing, monitoring, and treatment should be made by a licensed healthcare provider based on the individual patients clinical presentation, medical history, and applicable standard of care

Participants in clinical trials experienced up to a 20.9% reduction in body weight